Premium
Annovis Bio Inc (ANVS)
NYSE
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer’s disease, as well as in open-label phase 3 to treat parkinson’s disease. It also deve... Annovis Bio, Inc., a clinical stage drug platform company, develops drugs to treat neurodegeneration in the United States. The company’s lead product candidate is Buntanetap, which is in phase 3 to treat alzheimer’s disease, as well as in open-label phase 3 to treat parkinson’s disease. It also develops ANVS405, which is in phase 2 and 3 clinical trials for the treatment of traumatic brain injury and/or stroke; and ANVS301, which finished phase 1 clinical trial developed to increase cognitive capability in later stages of alzheimer’s disease and dementia. Annovis Bio, Inc. was incorporated in 2008 and is headquartered in Malvern, Pennsylvania. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.1595 | -8.22164948454 | 1.94 | 1.96 | 1.7 | 1148956 | 1.80423856 | CS |
| 4 | -0.2495 | -12.2906403941 | 2.03 | 2.385 | 1.7 | 1417242 | 1.96743537 | CS |
| 12 | -0.8595 | -32.5568181818 | 2.64 | 2.77 | 1.5407 | 1198312 | 1.9576664 | CS |
| 26 | -1.9895 | -52.7718832891 | 3.77 | 4.2399 | 1.5407 | 800940 | 2.29648214 | CS |
| 52 | -1.0195 | -36.4107142857 | 2.8 | 5.5 | 1.5407 | 934099 | 2.68342404 | CS |
| 156 | -11.9895 | -87.0697167756 | 13.77 | 22.49 | 1.11 | 640629 | 5.69110575 | CS |
| 260 | -93.2195 | -98.1257894737 | 95 | 132 | 1.11 | 453043 | 11.74720204 | CS |
Transactions différées
Pour obtenir des transactions en temps réel, améliorez votre compte
Passer à la version en temps réel| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
